Psychedelic Stocks

2020-08-20 PSW Editor

IntelGenX enters into agreement with ATAI Life Sciences to develop novel formulations of pharmaceutical-grade psychedelics.

2020-08-20 PSW Editor

ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.

2020-08-19 PSW Editor

Global Trac Solutions is developing a media partnership with Microdose.

2020-08-14 Jeff Nielson

Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.

2020-08-14 PSW Editor

Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.

2020-08-14 PSW Editor

MindMed reported a net loss of $5.8 million for first 6 months of 2020, has USD $24 million in cash.

2020-08-13 PSW Editor

MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.

2020-08-13 PSW Editor

Tryp Therapeutics adds a partner to advance its drug manufacturing capabilities.

2020-08-13 PSW Editor

MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.

2020-08-12 Jeff Nielson

There are obvious parallels between cannabis and psychedelics decriminalization. Are there are also differences?

2020-08-12 PSW Editor

Mydecine's corporate update notes its "world's first" clinical trials initiative for PTSD.

2020-08-12 PSW Editor

A new psychedelics company began trading August 11th.